Meet CIMM

To Make Healthy And Beautiful Life For Everyone

About Us

Changzhou Institute of Materia Medica Co., Ltd. (CIMM) is a innovative national high-tech enterprise originating as a provincial-level research institution established in 1984. As the China's earliest scientific organization specialized in the study of medical sodium hyaluronate gel, CIMM offers our worldwide customers efficient, flexible, and high-quality solutions for the Research and Development (R&D), Production, and Sales of medical device products.

  • 40 years of hyaluronic acid ingredient research
  • 30,000 ㎡ industrial base
  • 16,000 ㎡ GMP standard workshop
  • 60 Invention Patents

The main business directions of the enterprise are medical devices (Sodium Hyaluronate) and skin care products. The product categories cover surgical, ophthalmic, medical aesthetics, and skin care fields.

Development Milestones

Our Mission

TO MAKE HEALTHY AND BEAUTIFUL LIFE FOR EVERYONE

Our Values

Integrity, Uprightness, Inclusivity.

Respect and care for employees, providing opportunities for shared success.
Contribute to society with responsibility.
Overcome adversity and pursue higher goals relentlessly.

Business Philosophy

Continuously improve products through technological innovation and deliver premium services to agents, hospitals, and medical professionals.

Our Innovations

CIMM has always prioritized scientific research and development (R&D), technological collaboration, and intellectual property protection.
partnerships with institutionssuc has Germany's NMI Institute of Naturaland Medical Sciencesat the University of Tubingen,Nanjng Normal University,China
Through industry-university-research partnerships with institutions such as Germany’s NMI Institute of Natural and Medical Sciences at the University of Tübingen, Nanjing Normal University,
China Pharmaceutical University, Nanjing University of Science and Technology, Jiangnan University, and Xi’an Jiaotong University, CIMM co-develops cutting-edge biomedical products.

To date, the company holds 60 granted patents, comprising 30 invention patents, 12 utility model patents and 18 design patents.

A Great Team and Winning Culture

Strong R&D Team

CIMM is a member of the Global Harmonization Working Party (GHWP) and has obtained certifications including:

• ISO 9001:2015 Quality Management System

• ISO 13485:2016 Medical Device Quality Management System

• GB/T 23001-2017 (Informatization-Industrialization Integrated Management System Requirements)

• GB/T 23006-2022 (Advanced Capability Classification for Informatization-Industrialization Integrated Management Systems)

Quality Control

CIMM is a member of the Global Harmonization Working Party (GHWP) and has obtained certifications including:
• ISO 9001:2015 Quality Management System
• ISO 13485:2016 Medical Device Quality Management System
• GB/T 23001-2017 (Informatization-Industrialization Integrated Management System Requirements)
• GB/T 23006-2022 (Advanced Capability Classification for Informatization-Industrialization Integrated Management Systems)